---
title: "本週值得關注的分析師推薦中，輝瑞、AMD 和英特爾被列為首選"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/289668215.md"
description: "華爾街分析師本週發佈了顯著的評級調整。輝瑞、英特爾、AMD、Illumina 以及芯片設備製造商因風險回報平衡、人工智能潛力和強勁支出而獲得了升級。相反，耐克因復甦速度低於預期而被下調評級。儘管 SpaceX 進行了歷史性的首次公開募股，但由於對未驗證的商業成果的擔憂，CFRA 首次給予其 “賣出” 評級"
datetime: "2026-06-13T14:25:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289668215.md)
  - [en](https://longbridge.com/en/news/289668215.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289668215.md)
---

# 本週值得關注的分析師推薦中，輝瑞、AMD 和英特爾被列為首選

Major market indexes on Wall Street ended higher on Friday as the highly anticipated debut of SpaceX grabbed investors' attention. Wall Street had a slew of upgrades and downgrades from analysts. Here are some of the major calls for the week: Pfizer upgraded by RBC on risk-reward setup RBC upgraded Pfizer (PFE) to Sector Perform from Underperform, ...

### 相關股票

- [PFE.US](https://longbridge.com/zh-HK/quote/PFE.US.md)
- [ILMN.US](https://longbridge.com/zh-HK/quote/ILMN.US.md)
- [INTC.US](https://longbridge.com/zh-HK/quote/INTC.US.md)
- [SPCX.US](https://longbridge.com/zh-HK/quote/SPCX.US.md)
- [NKE.US](https://longbridge.com/zh-HK/quote/NKE.US.md)
- [04335.HK](https://longbridge.com/zh-HK/quote/04335.HK.md)
- [AMD.US](https://longbridge.com/zh-HK/quote/AMD.US.md)
- [AMUU.US](https://longbridge.com/zh-HK/quote/AMUU.US.md)
- [INTW.US](https://longbridge.com/zh-HK/quote/INTW.US.md)
- [AMDD.US](https://longbridge.com/zh-HK/quote/AMDD.US.md)
- [AMDL.US](https://longbridge.com/zh-HK/quote/AMDL.US.md)
- [SPCH.US](https://longbridge.com/zh-HK/quote/SPCH.US.md)
- [SPCF.US](https://longbridge.com/zh-HK/quote/SPCF.US.md)
- [SPAL.US](https://longbridge.com/zh-HK/quote/SPAL.US.md)
- [SNK.US](https://longbridge.com/zh-HK/quote/SNK.US.md)
- [SSPC.US](https://longbridge.com/zh-HK/quote/SSPC.US.md)
- [SPCU.US](https://longbridge.com/zh-HK/quote/SPCU.US.md)
- [RY.US](https://longbridge.com/zh-HK/quote/RY.US.md)

## 相關資訊與研究

- [看好 CPU 銷售與晶圓代工業務，美銀兩級跳調升英特爾投資評等](https://longbridge.com/zh-HK/news/289537643.md)
- [嘉澤股東會／通過配發現金股利 35 元 審慎樂觀今年下半年營運](https://longbridge.com/zh-HK/news/289561402.md)
- [高股息加持！輝瑞跌深 11% 後迎升評 RBC 看好兩大癌症新藥成轉機](https://longbridge.com/zh-HK/news/289397155.md)
- [SpaceX 可藉軌道資料中心少 45% 成本 彭博：三到五年內顛覆 AI 既有秩序](https://longbridge.com/zh-HK/news/289618355.md)
- [輝瑞獲 RBC 上調評級，估值重置迎管線關鍵催化劑](https://longbridge.com/zh-HK/news/289373887.md)